LONG-TERM RESULTS OF TARGET THERAPY WITH FIRST AND * SECOND-LINE TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

LONG-TERM RESULTS OF TARGET THERAPY WITH FIRST AND * SECOND-LINE TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

Aim: To assess long-term efficacy of firstand second-line tyrosine kinase inhibitors in non-selected patients with chronic myeloid leukemia in a real-life clinical setting.Materials and methods: The assessment is based on long-term results of a prospective single center comparative clinical trial th...

Full description

Bibliographic Details
Main Authors: L. L. Vysotskaya, A. K. Golenkov, E. V. Trifonova, T. A. Mitina, E. V. Kataeva, Yu. B. Chernykh
Format: Article
Language:Russian
Published: MONIKI 2016-02-01
Series:Alʹmanah Kliničeskoj Mediciny
Subjects:
chronic myeloid leukemia
imatinib
nilotinib
total survival
Online Access:https://www.almclinmed.ru/jour/article/view/79

Internet

https://www.almclinmed.ru/jour/article/view/79

Similar Items